CLINICAL EXPERIENCE WITH MITOMYCIN C (NSC-26980)

被引：0

作者：

WHITTINGTON, RM

CLOSE, HP

机构：

来源：

CANCER CHEMOTHERAPY REPORTS PART 1 | 1970年 / 54卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：195 / +

页数：1

共 50 条

[1] MITOMYCIN C (NSC-26980)--CLINICAL BROCHURE
CARTER, SK
CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1968, 1 (01): : 99 - &
[2] CLINICAL STUDY OF MITOMYCIN-C (NSC-26980) IN COLORECTAL CANCER
ANSFIELD, FJ
CANCER CHEMOTHERAPY REPORTS PART 1, 1969, 53 (05): : 287 - &
[3] MITOMYCIN-C (NSC-26980) - AN EVALUATION OF THE JAPANESE REPORTS
FRANK, W
OSTERBERG, AE
CANCER CHEMOTHERAPY REPORTS, 1960, (09): : 114 - 119
[4] EVALUATION OF DOSAGE SCHEDULES OF MITOMYCIN-C (NSC-26980) IN CHILDREN/N
SUTOW, WW
WILBUR, JR
VIETTI, TJ
VUTHIBHAGDEE, P
FUJIMOTO, T
WATANABE, A
CANCER CHEMOTHERAPY REPORTS PART 1, 1971, 55 (03): : 285 - +
[5] EVALUATION OF MITOMYCIN-C (NSC-26980) IN TREATMENT OF METASTATIC OSTEOGENIC SARCOMA
EVANS, AE
HEYN, RM
NESBIT, ME
HARTMANN, JR
CANCER CHEMOTHERAPY REPORTS PART 1, 1969, 53 (05): : 297 - &
[6] ORAL ACTIVITY OF MITOMYCIN C (NSC-26980) ON WALKER 256 (INTRAMUSCULAR) TUMOR
BRADNER, WT
CANCER CHEMOTHERAPY REPORTS, 1968, 52 (03): : 389 - &
[7] INTERMITTENT DOSE SCHEDULE OF MITOMYCIN-C (NSC-26980) IN SOLID TUMORS
KENIS, Y
STRYCKMA.P
CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (02): : 151 - &
[8] EFFECTS OF MITOMYCIN C (NSC-26980) IN 346 PATIENTS WITH ADVANCED CANCER - EASTERN CLINICAL DRUG EVALUATION PROGRAM
MOORE, GE
BROSS, IDJ
AUSMAN, R
NADLER, S
JONES, R
SLACK, N
RIMM, AA
CANCER CHEMOTHERAPY REPORTS, 1968, 52 (6P1): : 675 - &
[9] INFLUENCE OF SCHEDULE OF ADMINISTRATION OF MITOMYCIN-C (NSC-26980) IN TREATMENT OF L1210 LEUKEMIA
KOJIMA, R
GOLDIN, A
MANTEL, N
CANCER CHEMOTHERAPY REPORTS PART 2 SUPPLEMENT, 1972, 3 (01): : 111 - 119
[10] NEUROTOXICITY FROM 5-FLUOROURACIL (NSC-19893) ADMINISTRATION REPRODUCED BY MITOMYCIN-C (NSC-26980)
NICHOLS, M
BERGEVIN, PR
VYAS, AC
HAMLIN, R
CANCER TREATMENT REPORTS, 1976, 60 (03): : 293 - 294

← 1 2 3 4 5 →